Optimizing Maryland's Prescription Drug Monitoring Program (PDMP)

The Harold Rogers Prescription Drug Monitoring Program (PDMP) enhances the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized agency.

PDMPs help state and local governments to detect and prevent the diversion and abuse of pharmaceutically controlled substances such as opioids and other prescription drugs. The Harold Rogers PDMP strengthens states’ and territories’ ability to plan, implement, or enhance PDMPs by accommodating local decision-making based on state laws and preferences, while encouraging the replication of promising practices. In addition to supporting the implementation and enhancement of PDMPs, the program can support the Administration’s priority of tracking prescribing across providers and states through the integration of PDMPs and Electronic Health Records (EHRs) and Health Information Exchanges (HIEs) which are essential to promoting safe and responsible prescribing, while also assuring appropriate pain care.

The applicant will address the following objectives: improved clinical decision making at the point of care will be achieved through interstate data visualizations and patient alerts; improved prescribing practices of clinicians will be achieved through prescriber report cards, enhanced use mandate compliance calculations, an enhanced prescriber self-audit tool, and updated electronic unsolicited reporting notification functionality. Improved data reporting and analytics will be achieved through a user-updated master provider directory and analytic infrastructure enhancements for public health reports.

CA/NCF